ETHICON, Inc. Established in 1921, it is a subsidiary of Johnson & Johnson, a global healthcare company. ETHICON's headquarters are located in Somerville, New Jersey.

The company specializes in the development and manufacturing of surgical products and technologies. Its main products include sutures, surgical meshes, staplers, and precision instruments used in various surgical procedures. ETHICON is widely recognized for its advanced surgical solutions that enhance patient outcomes and promote efficiency in the operating room.

With a global presence, ETHICON operates in various countries worldwide. The company has several noteworthy subsidiaries, such as ETHICON Endo-Surgery, Inc., which focuses on minimally invasive surgical products, and ETHICON Biosurgery, which specializes in innovative biologic solutions for hemostasis and tissue repair. ETHICON is a leader in the medical device industry and holds a prominent market position.

It competes with other major players in the market, including Medtronic, Boston Scientific, and Stryker. ETHICON's global sales contribute significantly to the overall revenue of Johnson & Johnson. Over the years, ETHICON has achieved numerous milestones and made significant contributions to the medical field.

The company has been at the forefront of developing new surgical techniques and innovations, improving patient safety and surgical outcomes. In recent years, ETHICON has focused on expanding its product portfolio and developing advanced technologies to meet the evolving needs of healthcare professionals. It has introduced new surgical devices, such as the Echelon Flex™ GST System, which offers enhanced precision and control for surgeons.

As of the latest information available, ETHICON continues to advance its research and development efforts to address emerging healthcare challenges. The company remains committed to providing innovative solutions that improve patient care and support healthcare professionals worldwide